These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33854482)

  • 1. SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and/or Hirsutism and in Women With Sexual Dysfunction.
    Di Stasi V; Maseroli E; Rastrelli G; Scavello I; Cipriani S; Todisco T; Marchiani S; Sorbi F; Fambrini M; Petraglia F; Maggi M; Vignozzi L
    Front Endocrinol (Lausanne); 2021; 12():641446. PubMed ID: 33854482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal profile of women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland birth cohort 1966 study.
    Taponen S; Martikainen H; Järvelin MR; Laitinen J; Pouta A; Hartikainen AL; Sovio U; McCarthy MI; Franks S; Ruokonen A
    J Clin Endocrinol Metab; 2003 Jan; 88(1):141-7. PubMed ID: 12519843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
    Karrer-Voegeli S; Rey F; Reymond MJ; Meuwly JY; Gaillard RC; Gomez F
    Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex hormone-binding globulin, oligomenorrhea, polycystic ovary syndrome, and childhood insulin at age 14 years predict metabolic syndrome and class III obesity at age 24 years.
    Glueck CJ; Morrison JA; Daniels S; Wang P; Stroop D
    J Pediatr; 2011 Aug; 159(2):308-13.e2. PubMed ID: 21362574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
    Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
    Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
    Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
    J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database.
    Kumarendran B; O'Reilly MW; Manolopoulos KN; Toulis KA; Gokhale KM; Sitch AJ; Wijeyaratne CN; Coomarasamy A; Arlt W; Nirantharakumar K
    PLoS Med; 2018 Mar; 15(3):e1002542. PubMed ID: 29590099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome.
    Qu X; Donnelly R
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33139661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome.
    Pavičić Baldani D; Škrgatić L; Bukvić Mokos Z; Trgovčić I
    Acta Dermatovenerol Croat; 2013; 21(2):105-12. PubMed ID: 24001418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease is associated with hyperandrogenism in women with polycystic ovary syndrome.
    Hong SH; Sung YA; Hong YS; Song DK; Jung H; Jeong K; Chung H; Lee H
    Sci Rep; 2023 Aug; 13(1):13397. PubMed ID: 37591864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity regulates bioavailable testosterone levels in women with or without polycystic ovary syndrome.
    Penttilä TL; Koskinen P; Penttilä TA; Anttila L; Irjala K
    Fertil Steril; 1999 Mar; 71(3):457-61. PubMed ID: 10065782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin.
    Song MJ; Choi JY
    Front Endocrinol (Lausanne); 2022; 13():1053709. PubMed ID: 36482993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease is an influencing factor for the association of SHBG with metabolic syndrome in diabetes patients.
    Hua X; Li M; Pan F; Xiao Y; Cui W; Hu Y
    Sci Rep; 2017 Nov; 7(1):14532. PubMed ID: 29109457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective.
    Pasquali R; Zanotti L; Fanelli F; Mezzullo M; Fazzini A; Morselli Labate AM; Repaci A; Ribichini D; Gambineri A
    J Clin Endocrinol Metab; 2016 May; 101(5):2013-22. PubMed ID: 26964728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies.
    Escobar-Morreale HF; Asunción M; Calvo RM; Sancho J; San Millán JL
    Eur J Endocrinol; 2001 Nov; 145(5):619-24. PubMed ID: 11720881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCOS Features and Steroid Profiles Among Young Adult Women with a History of Premature Adrenarche.
    Tennilä J; Jääskeläinen J; Utriainen P; Voutilainen R; Häkkinen M; Auriola S; Morin-Papunen L; Liimatta J
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3335-e3345. PubMed ID: 34060603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of SHBG gene pentanucleotide TAAAA repeat and D327N polymorphism on serum sex hormone-binding globulin concentration in hirsute women.
    Cousin P; Calemard-Michel L; Lejeune H; Raverot G; Yessaad N; Emptoz-Bonneton A; Morel Y; Pugeat M
    J Clin Endocrinol Metab; 2004 Feb; 89(2):917-24. PubMed ID: 14764814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
    Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.